http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95f6da23e47f850bed9d1c9237ab0d3a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Konstantinopoulos |
| name | Panagiotis A. Konstantinopoulos Panagiotis A Konstantinopoulos |
| given-name | Panagiotis A Panagiotis A. |
| organization-name | Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts R. Wendel Naumann and James T. Symanowski, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, University of Texas, Houston; Michael G. Teneriello, Texas Oncology, Austin, TX; Robert A. Burger, Fox Chase Cancer Center, Philadelphia, PA; Edward A. Sausville, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Elzbieta Kutarska, Centrum Onkologii Ziemi Lubelskiej, Lubland; Elzbieta Nowara, Instytut im. Marii Skłodowskiej-Curie,... Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts. Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. Department of Hematology Oncology, Beth Israel Deaconess Medical Center , Boston, MA , USA; Department of Hematology Oncology, Dana-Farber Cancer Institute , Boston, MA , USA Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 5Dana-Farber Cancer Institute, Boston, Massachusetts. Division of Hematology/Oncology, Beth Israel Deconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Gynecologic Oncology Program Dana‐Farber Cancer Institute Boston Massachusetts Division of Gynecologic Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, US 1Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 2Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts Program in Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 227 Feldberg, East Campus, Boston, MA 02215, USA. [email protected] Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece; Division of Hematology–Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA 9Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Program of Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 1Division of Hematology/Oncology, Divisions of Hematology/Oncology and Infectious Diseases, and Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Division of Hematology/Oncology, Department of Medical Oncology Dana Farber Cancer Institute Boston MA 1Dana-Farber Cancer Institute, Boston, Massachusetts. 1Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece and; 2Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, MA Medical Gynecologic Oncology Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Department of Biological Chemistry, Medical School, University of Athens, 115 27 Athens, Greece; Division of Hematology and Oncology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Cedars-Sinai Medical Center, Los Angeles, CA; Howard Hughes Medical Institute, Chevy Chase, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; and Memorial Sloan-Kettering Cancer Center, New York, NY. Dana-Farber Cancer Institute, Boston, MA 02215, USA State University of New York Upstate Medical Center, Syracuse, NY 2Harvard Medical School, Boston, Massachusetts.; 5Medical Gynecology Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts.; 6Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, Massachusetts Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 3Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. 6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 7Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology Dana‐Farber Cancer Institute, Harvard Medical School Boston MA Division of Hematology–Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Authors' Affiliations: 1Program of Gynecologic Medical Oncology, Departments of 2Medicine and 3Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School; Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana Farber Cancer Institute, Harvard Medical School |
Incoming Links
Showing number of triples: 1 to 194 of 194.